LifeMD Inc
LFMD3.228USD
-0.002-0.06%
Market hours （ET）Quotes delayed by 15 min
150.37MMarket Cap
LossP/E TTM
More Details of LifeMD Inc Company
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
LifeMD Inc Info
Ticker SymbolLFMD
Company nameLifeMD Inc
IPO dateJul 11, 2001
CEOSchreiber (Justin)
Number of employees304
Security typeOrdinary Share
Fiscal year-endJul 11
Address236 Fifth Avenue
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10001
Phone18663515907
Websitehttps://lifemd.com/
Ticker SymbolLFMD
IPO dateJul 11, 2001
CEOSchreiber (Justin)
Company Executives of LifeMD Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%
Mr. Dennis Wijnker
Mr. Dennis Wijnker
Chief Technology Officer
Chief Technology Officer
135.00K
+22.73%
Dr. Joan Larovere
Dr. Joan Larovere
Independent Director
Independent Director
107.05K
+26.41%
Mr. Shane Biffar
Mr. Shane Biffar
Chief Compliance Officer and Deputy General Counsel
Chief Compliance Officer and Deputy General Counsel
40.00K
-73.33%
Mr. Calum Macrae, M.D., Ph.D.
Mr. Calum Macrae, M.D., Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Justin Schreiber
Mr. Justin Schreiber
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
2.85M
+7.23%
Mr. Stefan Galluppi
Mr. Stefan Galluppi
Chief Innovation Officer
Chief Innovation Officer
1.79M
+1.71%
Mr. Nicholas P. Alvarez
Mr. Nicholas P. Alvarez
Chief Acquisition Officer
Chief Acquisition Officer
495.71K
-13.14%
Mr. William J. (Will) Febbo
Mr. William J. (Will) Febbo
Director
Director
480.00K
+88.24%
Ms. Jessica Friedeman
Ms. Jessica Friedeman
Chief Marketing Officer
Chief Marketing Officer
220.00K
+29.41%
Mr. Roberto (Bob) Simon
Mr. Roberto (Bob) Simon
Independent Director
Independent Director
153.18K
+17.10%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
Other
77.13%
Shareholders
Shareholders
Proportion
Schreiber (Justin)
5.93%
BlackRock Institutional Trust Company, N.A.
5.21%
The Vanguard Group, Inc.
4.63%
Galluppi (Stefan)
3.71%
Renaissance Technologies LLC
3.39%
Other
77.13%
Shareholder Types
Shareholders
Proportion
Investment Advisor
20.73%
Individual Investor
17.81%
Investment Advisor/Hedge Fund
10.75%
Hedge Fund
7.90%
Research Firm
2.96%
Venture Capital
0.28%
Pension Fund
0.27%
Bank and Trust
0.09%
Insurance Company
0.03%
Other
39.17%
Institutional Shareholding
Updated: Sun, Oct 5
Updated: Sun, Oct 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
277
24.14M
53.61%
+2.76M
2025Q2
267
25.16M
55.86%
-4.75M
2025Q1
265
25.52M
57.64%
-4.18M
2024Q4
250
23.83M
55.01%
-4.80M
2024Q3
242
24.90M
57.80%
-2.33M
2024Q2
218
23.83M
56.29%
-290.09K
2024Q1
179
22.61M
56.88%
+2.36M
2023Q4
165
20.18M
54.63%
+3.17M
2023Q3
148
17.40M
50.33%
+1.98M
2023Q2
144
16.05M
50.66%
-1.42M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Schreiber (Justin)
2.85M
6.34%
+192.34K
+7.23%
Apr 23, 2025
BlackRock Institutional Trust Company, N.A.
2.41M
5.35%
+107.80K
+4.68%
Jun 30, 2025
The Vanguard Group, Inc.
2.09M
4.63%
+205.62K
+10.93%
Jun 30, 2025
Galluppi (Stefan)
1.79M
3.96%
+30.00K
+1.71%
Aug 22, 2025
Renaissance Technologies LLC
1.09M
2.41%
+600.10K
+123.45%
Jun 30, 2025
Nuveen LLC
1.14M
2.53%
+854.91K
+300.99%
Jun 30, 2025
State Street Investment Management (US)
1.14M
2.53%
+413.24K
+57.01%
Jun 30, 2025
Geode Capital Management, L.L.C.
925.17K
2.05%
+67.44K
+7.86%
Jun 30, 2025
UBS Financial Services, Inc.
937.33K
2.08%
+859.44K
+1103.45%
Jun 30, 2025
Royce Investment Partners
770.45K
1.71%
-384.78K
-33.31%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Kensho New Econ Comp ETF
0.09%
Vanguard US Multifactor ETF
0.08%
Vanguard US Momentum Factor ETF
0.06%
Principal U.S. Small-Cap ETF
0.06%
iShares Micro-Cap ETF
0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Quality Growth Fund
0.02%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
View more
State Street SPDR S&P Kensho New Econ Comp ETF
Proportion0.09%
Vanguard US Multifactor ETF
Proportion0.08%
Vanguard US Momentum Factor ETF
Proportion0.06%
Principal U.S. Small-Cap ETF
Proportion0.06%
iShares Micro-Cap ETF
Proportion0.04%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of LifeMD Inc?
The top five shareholders of LifeMD Inc are:
Schreiber (Justin) holds 2.85M shares, accounting for 6.34% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.41M shares, accounting for 5.35% of the total shares.
The Vanguard Group, Inc. holds 2.09M shares, accounting for 4.63% of the total shares.
Galluppi (Stefan) holds 1.79M shares, accounting for 3.96% of the total shares.
Renaissance Technologies LLC holds 1.09M shares, accounting for 2.41% of the total shares.
Schreiber (Justin) holds 2.85M shares, accounting for 6.34% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 2.41M shares, accounting for 5.35% of the total shares.
The Vanguard Group, Inc. holds 2.09M shares, accounting for 4.63% of the total shares.
Galluppi (Stefan) holds 1.79M shares, accounting for 3.96% of the total shares.
Renaissance Technologies LLC holds 1.09M shares, accounting for 2.41% of the total shares.
What are the top three shareholder types of LifeMD Inc?
The top three shareholder types of LifeMD Inc are:
Schreiber (Justin)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Schreiber (Justin)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
How many institutions hold shares of LifeMD Inc (LFMD)?
As of 2025Q3, 277 institutions hold shares of LifeMD Inc, with a combined market value of approximately 24.14M, accounting for 53.61% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.25%.
What is the biggest source of revenue for LifeMD Inc?
In --, the -- business generated the highest revenue for LifeMD Inc, amounting to -- and accounting for --% of total revenue.
